Acquisition of Aquila Biolabs GmbH (Details 1) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Earnings per share basic		$ (1.00)
Earnings per share Diluted		$ (1.00)
Revenues	$ 11,400,500	$ 9,775,200
Net loss	$ (5,644,400)	(3,672,500)
Pro forma information
Revenues		10,023,200
Net loss		$ (4,476,500)